SCHEMBL25251045

SCHEMBL25251045

COc1cccc(CN(Cc2cccc(N3CCCC3)c2)c2cccc(OCCOCCOCc3ccccc3)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 2/20 0.44
▸ CETP P11597 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MAOB P27338 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ QPCT Q16769 1/20 0.40
▸ MTNR1A P48039 1/20 0.39
▸ MTNR1B P49286 1/20 0.39
▸ LTA4H P09960 1/20 0.39
▸ F2R P25116 2/20 0.39
▸ AGXT P21549 1/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30245124 1.00 HRH3 (0.44) HRH3CETPKDM4EMAOBKIT
SCHEMBL25250533 0.93 HRH3 (0.50) HRH3CETPKDM4EQPCTLTA4H
SCHEMBL30245324 0.93 HRH3 (0.50) HRH3CETPKDM4EQPCTLTA4H
SCHEMBL25295970 0.93 LTA4H (0.43) HRH3KDM4EMAOBKITFLT3
SCHEMBL30245340 0.91 HRH3 (0.40) HRH3CETPKDM4EQPCTLTA4H
SCHEMBL25257585 0.91 HRH3 (0.40) HRH3CETPKDM4EQPCTLTA4H
SCHEMBL30244966 0.90 HRH3 (0.40) HRH3KDM4EKITFLT3QPCT
SCHEMBL25250353 0.90 HRH3 (0.40) HRH3KDM4EKITFLT3QPCT
SCHEMBL25254098 0.89 AGXT (0.46) HRH3CETPKDM4EQPCTAGXT
SCHEMBL30245329 0.89 AGXT (0.46) HRH3CETPKDM4EQPCTAGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018472-A9 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-07-13 — — WO claimed
WO-2023018472-A9 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-07-13 — — WO disclosed
Send feedback